Pediatrics

New research suggests sleep is an additional risk factor affecting myopia onset and progression.

The study found that pseudophakic children older at the time of surgery developed a glaucoma-related adverse event less frequently.

In a sham device-controlled, randomized, double-blind clinical trial in China, researchers utilized a device that emits 650 nm red light directly to the retina.

Pediatric glaucoma, although rare, can cause irreversible vision loss and leave children visually impaired if not treated timely and adequately.

Although the 20-20-20 rule is still a solid recommendation, recent studies have provided practitioners with more specific recommendations to help potentially prevent the onset and slow the progression of myopia.

A look back on what happened in optometry during the week of March 20-March 24.

REACH operates with three objectives: 1) eliminate barriers to eye health for school children; 2) improve the quality of school eye health services; and 3) create a positive, sustainable environment at schools where eye health services are provided, ensuring children feel comfortable to access these services.

Ashley Wallace-Tucker, OD, FAAO, FSLS, Dipl ABO, shares key takeaways from her SECO 2023 panel discussion, "Myopia management."

Aflibercept, a VEGF inhibitor previously indicated for a variety of retinal diseases, is the first pharmacological treatment for retinopathy of prematurity in preterm infants.

Protecting children’s eye health will demand a focus on vision and learning through better nutrition, myopia management, and disease prevention.

Second global virtual event on myopia management scheduled for February 16, 2023.

As our dependence on technology progresses, we have seen tremendous impact on all aspects of our lives—including our kids’ eyes and vision.

As 2022 comes to a close, check out some of the hottest and most-liked stories from the year!

Nidhi Rana, OD, discusses key highlights from her AAOpt 2022 presentation on pediatric red eye.

Three experts in myopia control convened at the Optometry Times EyeCon meeting to discuss methods to control this burgeoning global epidemic.

The submission is supported by positive phase 3 data, which shows quick reversal of dilation and favorable safety and tolerability.

The #GlassesOn campaign promotes the benefits of eyewear for kids and invites support for the non-profit through Giving Tuesday on November 29th.

Research indicates that too much technology usage results in negative effects on eyesight.

Enhanced treatments, tools, and resources make a difference.

Contact lenses can be beneficial for children, even when not medically necessary, explains Jennifer Fogt, OD, FAAO, FSLS.

Graham Erickson, OD, FAAO, FCOVD, shares highlights from his 2022 American Academy of Optometry presentation, "Evidence-based refractive prescribing for pediatric patients."

The CHAMP phase 3 study shows strong safety and efficacy of NVK002 for the treatment of myopia.

Vitto Mena, Jr., OD, MS, shares highlights from his discussion titled, "Contact lenses for kids: concepts and methods for contemporary care," which he co-presented during the 2022 American Academy of Optometry meeting.

Michelle Buckland, OD, MS, FAAO, shares highlights from her 2022 American Academy of Optometry presentation, "Pediatric eye exams: the ABCs and 123s."

Christina Twardowski, OD, FAAO, and Erin D. Stahl, MD, share highlights from their discussion titled, "A collaborative approach to pediatric keratoconus," which they presented during the 2022 American Academy of Optometry meeting.

Awareness of visual impairment in clinical practice is suboptimal, and adherence to ophthalmologic evaluation needs to be improved. The prospective cohort study in the Netherlands included 170 children aged 0 to 18 years with a newly diagnosed brain tumor.

Michelle Hoff, OD, FAAO, ABOM, FNAO, and Isabel Kazemi, OD, FAAO, share key takeaways from their VEW 2022 presentation, "The ABCs on pediatric vision."

At Vision Expo West 2022, Valerie M. Kattouf, OD, shares her best practices for managing prescription formulas for pediatric patients.

Clinical pilot study evaluates effect after 1 month of wear.

Researchers in Tokyo found that nearly 50% of preschoolers are myopic, indicating that the disease has reached epidemic proportions.